These effects, together with a prior report displaying that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 support the idea of focusing on ACKR3 as a novel strategy to modulate the opioid process, which could open up new therapeutic avenues for opioid-associated Conditions. The complement is intended https://nickg616uwu2.thechapblog.com/profile